Clinical trials
Osteoporosis clinical trials
Below are recruiting osteoporosis clinical trials, each written for real people, not researchers. We’re tracking 132 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07486076Enrolling by invitation
Osteoporosis education for women at risk
This trial tests whether an education program can improve women's understanding and beliefs about osteoporosis. If you are a woman over 45 without osteoporosis but with risk factors, you may be able to join and learn ways to protect your bone health.
BartınAges 45–80 - NCT06525688Recruiting
Osteoporosis study using bone tissue to find new targets
This study looks for new markers and treatment targets for osteoporosis by comparing bone tissue from women with a broken hip (due to weak bones) and women getting a hip replacement for arthritis. You may be eligible if you are postmenopausal and have one of these hip conditions.
Kifissia, AtticaAges Any age - NCT07406685RecruitingPhase 4
Comparing two bone medicines after stopping denosumab
This study compares two medicines (ibandronate and zoledronic acid) to see which one works better at keeping bones strong after stopping denosumab (Prolia). It's for postmenopausal women with mild to moderate bone thinning.
TaipeiAges 50–85 - NCT07739628Enrolling by invitation
Testing a computer tool for osteoporosis screening from CT scans
This study checks if a new computer program can find people at risk for osteoporosis more easily, using CT scans you already had. If you are found to be high risk, you'll get a free bone density test (DXA) to confirm, and help improve this tool.
Wuhan, HubeiAges 18 years+ - NCT06431867Recruiting
Managing osteoporosis in older women
This study tests a new way for primary care doctors to help older women manage osteoporosis. It aims to find better strategies for treatment and follow-up in the community.
Bradford, West YorkshireAges 70 years+ - NCT06475794Recruiting
Q angle in women with osteoporosis
This study explores the Q angle (a measure of knee alignment) in women with osteoporosis. It may help understand how bone health affects knee mechanics.
ElâzığAges 18–65 - NCT06551155Recruiting
Blood test to screen bone health and fracture risk
This study uses a simple blood test to look for early signs of bone loss and fracture risk. It's for people 40 and older who are either healthy, have early bone thinning, or have known osteoporosis.
BolognaAges 40 years+ - NCT06915935Recruiting
Osteoporosis study in older adults in Shandong
This trial is a study to understand how common osteoporosis is in people aged 65 and older living in Shandong province. By joining, you help researchers learn more about bone health in older adults.
Jinan, ShandongAges 65 years+ - NCT06938152RecruitingPhase 4
Comparing two bone-strengthening drug schedules for osteoporosis
This trial tests whether switching between two medications (Romosozumab and Denosumab) using a cycle or sequence schedule works better for improving bone density in postmenopausal women with severe osteoporosis. It aims to find the most effective treatment plan.
TaipeiAges 50–90 - NCT07367776Recruiting
Online education program for osteoporosis (RCT-PATOS)
This trial tests a digital education program for people with osteoporosis or osteopenia. It aims to help you learn more about your bone health and how to manage it, all from home using the 1177.se platform.
GävleAges 50 years+ - NCT06395883Recruiting
Steroids and Your Bones in Joint Disease
This study looks at how steroids affect bone health in people with inflammatory joint diseases like rheumatoid arthritis. Researchers will track markers in your blood to see if short-term steroid use impacts your bones.
DrammenAges 25–90 - NCT05132348Recruiting
Studying immune markers in people with osteoporosis
This study looks at immune system “fingerprints” (immunophenotyping) in adults who have been diagnosed with osteoporosis. It may help researchers understand what drives osteoporosis and could guide better future treatments.
Bonn, Northrhine WestfaliaAges 18 years+ - NCT07296471Recruiting
Vitamin D and Bone Health Study
This study is looking at how vitamin D levels relate to bone health and overall health markers in people with and without osteoporosis. It aims to find better ways to understand and treat bone loss.
Yichang, HubeiAges 18 years+ - NCT07228611Recruiting
Osteoporosis risk after stroke
This study looks at bone health in people who have had a stroke. It aims to find out who is at risk for weak bones (osteoporosis) after a stroke, so doctors can help prevent fractures.
Ankara, YenimahalleAges 55–85 - NCT06741956Enrolling by invitation
Wearable device for osteoporosis prevention in women
This trial tests a wearable device designed to help prevent osteoporosis and reduce fracture risk in women who have recently gone through menopause. The goal is to see if the device can help you stay active and lower your chances of breaking a bone.
Seville, SpainAges 40 years+ - NCT07365514RecruitingPhase 1
Blackcurrants study for bone health in postmenopausal women
This trial tests if taking a blackcurrant supplement can help maintain bone density and reduce osteoporosis risk in postmenopausal women. You will take daily capsules and provide blood, stool, and bone scan samples over the study period.
Storrs, ConnecticutAges 45–70 - NCT02958020Recruiting
Osteoporosis study for adults age 45 to 79
This study collects health information to learn more about osteoporosis and who is most at risk. It may help researchers better understand prevention and early detection, based on your survey responses and basic health details.
Shenzhen, GuangdongAges 45–79 - NCT03755193RecruitingPhase 2
Testing another osteoporosis medicine after 2 years of denosumab
This study looks at how well and how safely another osteoporosis medicine works for people who have already taken denosumab for 2 years. It may help find the best next step to strengthen bones and lower fracture risk after denosumab.
Matsumoto, NaganoAges 20–120 - NCT05039216Recruiting
Biobank for inflammatory arthritis and osteoporosis
This study collects and stores health information and samples for people with long-term inflammatory arthritis (like rheumatoid arthritis, spondyloarthritis, or psoriatic arthritis) or with osteoporosis. It helps researchers understand these conditions and may lead to better future treatments.
ToulouseAges 18–99 - NCT05202678Recruiting
Check a new therapy for osteoporosis-related hip bone loss
This trial studies AGN1 LOEP, a treatment being tested to improve bone strength in people with osteoporosis-related bone loss in the hip. If you qualify, you would be followed over time with clinic visits and testing to see how the treatment affects your bone health.
Sint-Niklaas, AntwerpenAges Any age - NCT05228262Recruiting
Testing blood-vessel function and muscle strength in osteoporosis
This study looks at how well your blood vessels work and how strong your muscles are, in women after menopause with osteoporosis. You may be asked to start standard osteoporosis treatment, and the researchers will study pain and changes related to vascular function and sarcopenia (loss of muscle and strength).
Clermont-FerrandAges 50 years+ - NCT05571514Recruiting
Pearl supplement study to help prevent menopause-related bone loss
This study tests whether a “mother-of-pearl” nutritional supplement can help prevent osteoporosis after menopause. You may qualify if you’re a post-menopausal woman with lower-than-normal bone density but without past fragility fractures.
Clermont-FerrandAges 50–65 - NCT05688969Recruiting
Study of how an osteoporosis shot works in postmenopausal women
This study looks at what changes in the body after starting romosozumab (an osteoporosis treatment) in postmenopausal women at higher risk for fractures. Researchers want to understand the treatment’s “mechanism,” which may help improve future osteoporosis care.
Boston, MassachusettsAges 45 years+ - NCT05787808Recruiting
Preventive treatment for people with early bone loss
This trial studies a preventive treatment for people over 55 who have early bone thinning (called osteopenia). If you qualify, it may help reduce the risk of getting osteoporosis and related fractures.
Skjetten, AkershusAges 55–85
Hear when a new Osteoporosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Osteoporosis trials by city
Studies with a site in or near these metro areas.
Osteoporosis trials by state
Studies with a site anywhere in these states.
Common questions
- Are there clinical trials for osteoporosis?
- Yes. Clin2 currently lists 132 recruiting osteoporosis studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a osteoporosis trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a osteoporosis trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.